Cargando…
(Acetato-κO)(acetato-κ(2) O,O′)[2-(3,5-dimethyl-1H-pyrazol-1-yl-κN (2))quinoline-κN]zinc(II)
The Zn(II) atom in the title compound, [Zn(C(2)H(3)O(2))(2)(C(14)H(13)N(3))], is coordinated by an N(2)O(3) donor set defined by the quinolinyl- and pyrazolyl-N atoms of the chelating heterocyclic ligand, and three carboxylate-O atoms derived from the monodentate and bidentate carboxylate ligands....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393171/ https://www.ncbi.nlm.nih.gov/pubmed/22807739 http://dx.doi.org/10.1107/S1600536812025664 |
Sumario: | The Zn(II) atom in the title compound, [Zn(C(2)H(3)O(2))(2)(C(14)H(13)N(3))], is coordinated by an N(2)O(3) donor set defined by the quinolinyl- and pyrazolyl-N atoms of the chelating heterocyclic ligand, and three carboxylate-O atoms derived from the monodentate and bidentate carboxylate ligands. Distortions from the ideal square-pyramidal coordination geometry relate to the restricted bite angle of the chelating ligands, i.e. O—Zn—O = 59.65 (5) and N—Zn—N = 76.50 (6)°, and the close approach of the non-coordinating carbonyl atom [Zn⋯O = 2.858 (2) Å]. In the crystal, molecules are consolidated into a three-dimensional architecture by C—H⋯O interactions |
---|